"A FIVE-DAY COURSE of molnupiravir, the new medicine being hailed as a 'huge advance' in the treatment of Covid-19. the pill could bring staggering profits to both Merck and Ridgeback Biotherapeutics Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price."IN OTHER FLU-GOO NEWS:
-- COPENHAGEN, Denmark (AP) - "Swedish health authorities on Wednesday suspended the use of Moderna's COVID-19 vaccine for those ages 30 and under, saying the move was done out of precaution."
